Elsevier

Contraception

Volume 28, Issue 1, July 1983, Pages 77-85
Contraception

Binding of the anti-progestin ru-486 to rat ovary steroid receptors*

https://doi.org/10.1016/S0010-7824(83)80008-0Get rights and content

Abstract

RU-486 is a recently synthesized steroid with anti-progesterone and anti-glucocorticoid properties. Its direct anti-progesterone action on the uterus is believed to be the basis for its ability to induce menstruation and early abortion. RU-486 likely antigonizes progesterone action on the uterus progesterone receptor. We have studied the binding of RU-486 to rat ovary steroid receptors in order to learn whether this interesting synthetic compound binds to ovary steroid receptors and thus learn if this antagonist can be used to better define the mechanism(s) of steroid actions on the ovary. Ovaries from estrogen stimulated hypophysectomized immature female rats were homogenized in buffer. The 100,000 x g supernatant was incubated with tritiated steroid agonists (R5020, dexamethasone, or testosterone) alone or with unlabeled steroids including RU-486. Receptor bound, and free steroid, were separated by Sephadex G-200 columns. The relative abilities of the various tested steroids to bind to the rat ovary progesterone receptor were: RU-486 ≥ R5020 > progesterone. RU-486 bound to the ovary glucocorticoid receptor with an affinity equal to that of dexamethasone. The affinity of RU-486 for the rat ovary androgen receptor was only about 9% that of testosterone. Thus, RU-486 binds with very high affinity to the rat ovary progesterone and glucocorticoid receptors. This steroid receptor antagonist offers a new tool by which the mechanism(s) of action of these steroids on the ovary can be tested.

References (11)

There are more references available in the full text version of this article.

Cited by (67)

  • Aldosterone Mediated Regulation of Epithelial Sodium Channel (ENaC) Subunits in the Rat Hypothalamus

    2018, Neuroscience
    Citation Excerpt :

    RU-28318 used for incubations was 2.5 μM, whereas that of RU-486 was 5 μM. The concentration of these competitive antagonists was determined based on published reports that RU-28318 and RU-486 competitively bind to the receptor with an affinity similar to that of the mineralocorticoid (Janiak and Brody, 1988) and glucocorticoid (Schreiber et al., 1983). The final concentration of DMSO in ACSF was 0.05% when aldosterone or corticosterone was applied and 0.1% when MR or GR antagonists were applied in addition to aldosterone or corticosterone.

  • Increased ventilation in female erythropoietin-deficient mouse line is not progesterone and estrous stage-dependent

    2017, Respiratory Physiology and Neurobiology
    Citation Excerpt :

    As no effects was observed, only treatment with Mifepristone was used in this set of experiments. Mifepristone is a mixed antagonist of progesterone and glucocorticoid receptors, which permits to this synthetic steroid compound to bind with very high affinity to progesterone and glucocorticoid receptors in rats (Schreiber et al., 1983). Furthermore, mifepristone also binds weakly to the androgen receptor and might also have a weak anti-androgenic activity (Schreiber et al., 1983).

  • Mineralocorticoid receptor antagonists attenuate pulmonary inflammation and bleomycin-evoked fibrosis in rodent models

    2013, European Journal of Pharmacology
    Citation Excerpt :

    Consequently, it is unlikely that the anti-inflammatory activities of MR antagonists observed in the current report are mediated by stimulation of GR. In support of this assertion, we were unable to show that the nasal effect of eplerenone was impacted by prior treatment with the GR/PR antagonist, RU486 (Jung-Testas and Baulieu 1983; Schreiber et al., 1983). We speculate that the anti-inflammatory actions of MR antagonists in the respiratory system may be driven by comparable mechanisms that may direct the anti-inflammatory actions of RAAS blockers in the adipose tissues, in the CNS and in the renal and cardiovascular systems (Hu et al., 2005; Pearce et al., 2003; Satofuka et al., 2009; Stegbauer et al., 2009; Montecucco et al., 2009; Gilbert and Brown, 2010; Frieler et al., 2011).

  • Antagonism of progesterone receptor suppresses carotid body responses to hypoxia and nicotine in rat pups

    2012, Neuroscience
    Citation Excerpt :

    However, it appears that mechanisms related to postnatal body growth are under the influence of either the progesterone or corticosteroid receptor and warrants further investigation to be better understood. Mifepristone is a synthetic steroid compound that binds with very high affinity to the rat progesterone and glucocorticoid receptors (Healy et al., 1983a,b; Jung-Testas and Baulieu, 1983; Schreiber et al., 1983; Moguilewsky and Philibert, 1984) forming an inactive complex. This is one of the few available antagonists for these receptors.

View all citing articles on Scopus
*

Supported by NIH Grant HD-17753, HD-12304d, and the Mother's Aid Research Fund.

View full text